Selling the Cannabis Bubble (Part 2)
Updated
The pot bubble is going to burst. From the technical perspective we are pulling the trigger here after retracing 61.8% of the initial leg to the downside from the highs. For those who believe in the bearish story for the industry, now is the time to get back to work on the sell-side. More and more funds with large central books are starting to open up positions writing upside vol from here onwards. The easier play in this field is to just short the common stock with targets at the bottom of the range.
The drug although very safe does not have any reasonable medical benefits. Obviously we have the lifestyle/recreational benefit but not any obvious health benefit other than epileptic syndromes. I do think it has some analgesic properties but these have to be understood through more clinical trials and et... to put simply we need more robust toxicology and clinical understanding here before any further upside is unlocked.
Best of luck those who are already positioned on the sell side in
WEED and the others.
The drug although very safe does not have any reasonable medical benefits. Obviously we have the lifestyle/recreational benefit but not any obvious health benefit other than epileptic syndromes. I do think it has some analgesic properties but these have to be understood through more clinical trials and et... to put simply we need more robust toxicology and clinical understanding here before any further upside is unlocked.
Best of luck those who are already positioned on the sell side in
WEED and the others. Note
-5.8% !!Note
A rough day for pot stocks... -4.6% !!!Trade closed: target reached
First targets cleared at 4.58 ... well done all those holding shorts. A flawless -60% call so far and counting !!!!Note
Trade closed: target reached
Major updates from the Cannabis sector...
ACB clearing all targets at the test of 2.5, a flawless -73% swing.Note
Headed for zero...Note
Lol... a reverse split after threats of delisting! Complete trash...
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.